Literature DB >> 33089682

Artatrovirenols A and B: Two Cagelike Sesquiterpenoids from Artemisia atrovirens.

Li-Hua Su1,2, Chang-An Geng1, Tian-Ze Li1, Yun-Bao Ma1, Xiao-Yan Huang1, Xue-Mei Zhang1, Ji-Jun Chen1,2.   

Abstract

Artatrovirenols A and B (1 and 2), two novel cagelike sesquiterpenoids, possess a unique 5/5/6/5/5-pentacyclic and a 5/5/6/5-tetracyclic system with an unprecedented tetracyclo[5.3.1.1.4,1101,5]dodecane scaffold from Artemisia atrovirens. The structures of compounds 1 and 2 including their absolute stereochemistry were elucidated through extensive spectroscopic analyses, X-ray crystallography, and quantum chemical calculations. Plausible biosynthetic pathways for the new isolates were proposed from the naturally occurring arglabin (3) via the key intramolecular Diels-Alder cycloaddition. Compound 1 showed cytotoxicity against three human hepatoma cell lines (HepG2, SMMC-7721, and Huh7) with half maximal inhibitory concentration values of 123.8, 44.0, and 142.6 μΜ, respectively.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33089682     DOI: 10.1021/acs.joc.0c01491

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Design and synthesis of ludartin derivatives as potential anticancer agents against hepatocellular carcinoma.

Authors:  Jin-Jin Sun; Jin-Ping Wang; Tian-Ze Li; Yun-Bao Ma; Dong Xue; Ji-Jun Chen
Journal:  Med Chem Res       Date:  2022-05-24       Impact factor: 2.351

2.  Artemyrianosins A-J, cytotoxic germacrane-type sesquiterpene lactones from Artemisia myriantha.

Authors:  Xin Zhang; Yun-Bao Ma; Xiao-Feng He; Tian-Ze Li; Chang-An Geng; Li-Hua Su; Shuang Tang; Zhen Gao; Ji-Jun Chen
Journal:  Nat Prod Bioprospect       Date:  2022-05-02

3.  Sarcoeleganolides C-G, Five New Cembranes from the South China Sea Soft Coral Sarcophyton elegans.

Authors:  Cili Wang; Jiarui Zhang; Xing Shi; Kai Li; Fengling Li; Xuli Tang; Guoqiang Li; Pinglin Li
Journal:  Mar Drugs       Date:  2022-09-10       Impact factor: 6.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.